Point72 Hong Kong LTD Lexicon Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $4,719 - $9,692	-3,603 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $7,025 - $14,015	3,603 New	3,603 $8,000
Q2 2021 Aug 16, 2021	SELL	$4.12 - $5.87 $234 - $334	-57 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $196 - $518	57 New	57 $0
Q1 2019 May 15, 2019	SELL	$4.36 - $7.94 $1,194 - $2,175	-274 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $1,685 - $2,879	274 New	274 $2,000
Q2 2018 Aug 14, 2018	SELL	$7.8 - $13.69 $553 - $971	-71 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $558 - $808	71 New	71 $1,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $2,236 - $3,131	-255 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $3,103 - $4,156	255	255 $3,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.